VR1 Antibodies

Santa Cruz Biotechnology offers a broad range of VR1 Antibodies for advanced research in the field of pain and sensory signaling. Monoclonal VR1 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VR1, also known as TRPV1, plays a crucial role in the detection of noxious stimuli and is involved in the sensation of pain. As a key player in the inflammatory response, VR1 has been implicated in various pain-related disorders. Understanding VR1's molecular mechanisms is essential for developing potential therapeutic strategies. Research utilizing VR1 monoclonal antibodies enables scientists to explore pain pathways and sensory perception at the molecular level. Investigating VR1's functions and interactions provides valuable insights into cellular signaling networks. The molecular characterization of VR1 continues to advance our understanding of pain mechanisms. Santa Cruz Biotechnology monoclonal VR1 antibodies support researchers worldwide in their pursuit of innovative pain management solutions and treatments.